← FDA Drug Approvals (Drugs@FDA)

OJJAARA

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2023-09-15

Drug application

FDA Application #

NDA216873

Application type

New Drug Application

Brand name

OJJAARA

Generic name

MOMELOTINIB

Active ingredients

MOMELOTINIB DIHYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE

Manufacturer

GlaxoSmithKline LLC

First approval

2023-09-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown